VR Logo

Unrated

UTI Healthcare Fund - Regular Plan


1 Lakh

Investment declined to
₹ 1.00 Lakh

₹ 10000

Monthly SIP Declined to
₹ 3.50 Lakh

Analyst's Choice?

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends paid by the mutual fund scheme are taxed at the rate of 10% (effectively 11.648%, including surcharge and cess). This is known as Dividend Distribution Tax (DDT). Though the investor does not pay this tax directly, it is deducted from the dividend income before passing on to the investor.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 4.42 8.40 10.76 -0.86 4.24 18.42 3.35 -0.12 -3.44 9.57 9.86
S&P BSE Healthcare TRI 0.95 8.95 11.16 -3.17 0.78 13.24 -4.68 -3.16 -5.47 8.06 10.40
Equity: Sectoral-Pharma 5.39 8.48 10.50 -1.68 5.18 17.68 7.51 1.33 -1.83 11.22 11.59
Rank within category 7 6 5 5 6 3 7 3 2 3 3
Number of funds in category 9 9 9 9 9 9 8 4 3 3 3

As on 07-Apr-2020

Best & Worst Performance

Best (Period) Worst (Period)
Week 13.12 (14-Jun-2006 - 21-Jun-2006) -16.12 (15-Jan-2008 - 22-Jan-2008)
Month 18.81 (21-Jul-2006 - 21-Aug-2006) -31.35 (09-May-2006 - 08-Jun-2006)
Quarter 34.19 (09-Mar-2009 - 10-Jun-2009) -27.70 (02-Sep-2008 - 03-Dec-2008)
Year 99.77 (25-Mar-2009 - 25-Mar-2010) -26.83 (31-Dec-2007 - 30-Dec-2008)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -2.50 15.77 -0.51 -0.82 0.84 1.09
S&P BSE Healthcare TRI -5.34 18.13 -0.60 -1.07 -- --
Equity: Sectoral-Pharma -0.97 15.89 -0.40 -0.64 0.83 2.57
Rank within category 3 3 3 3 3 3
Number of funds in category 4 4 4 4 4 4

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Mar-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 25
Top 10 Stocks (%) 61.23
Top 5 Stocks (%) 35.50
Top 3 Sectors (%) 98.14
Portfolio P/B Ratio 3.45
Portfolio P/E Ratio 26.67

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 22,649 22,876
Giant (%) -- 1.78
Large (%) 29.81 37.31
Mid (%) 57.62 48.19
Small (%) 12.56 14.30
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Cipla Healthcare 23.78 9.70 3.52 9.15
down Divi's Laboratories Healthcare 43.15 9.43 0.00 7.49
down Sun Pharmaceutical Inds. Healthcare 25.01 17.25 5.73 6.63
equal Ipca Laboratories Healthcare 31.12 7.79 2.06 6.28
equal Lupin Healthcare -- 9.90 0.00 5.95
up Dr. Reddy's Lab Healthcare 35.02 9.66 0.00 5.83
equal Ajanta Pharma Healthcare 27.35 5.75 0.00 5.58
equal Cadila Healthcare Healthcare 25.70 9.87 1.26 5.53
down Aurobindo Pharma Healthcare 10.17 10.12 2.36 4.43
equal FDC Healthcare 16.19 4.36 0.31 4.36
equal Torrent Pharmaceuticals Healthcare 71.48 8.05 0.68 3.61
up Narayana Hrudayalaya Healthcare 39.17 3.49 0.00 3.49
equal Eris Lifesciences Healthcare 17.58 4.47 0.00 3.40
equal Biocon Healthcare 45.52 3.35 0.00 3.31
up Apollo Hospitals Healthcare 53.19 3.05 0.00 3.05
equal Sanofi India Healthcare 39.05 6.60 2.62 2.97
equal Syngene International Healthcare 27.77 3.12 0.00 2.96
equal Natco Pharma Healthcare 21.12 4.33 0.00 2.95
equal Abbott India Healthcare 59.70 2.39 0.00 2.39
equal Dr. Lal Pathlabs Healthcare 48.09 2.94 1.62 2.21
equal Pfizer Healthcare 37.80 7.52 1.23 1.74
equal Alkem Laboratories Healthcare 25.11 8.56 1.18 1.53
equal Metropolis Healthcare Healthcare 44.05 1.28 0.00 1.28
up Advanced Enzyme Technologies FMCG 11.80 1.08 0.00 1.08
down Glaxosmithkline Pharma Healthcare 267.53 2.77 0.00 0.94

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 29-Feb-2020

Fund Manager

— V Srivatsa since 02-Mar-2017

Education: Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.

Experience: Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.

Funds Managed:


8.40%

Change from previous, NAV as on 07-Apr-2020

Growth: ₹ 88.7391

Dividend: ₹ 68.5827


Investment Strategy

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 6
Minimum Withdrawal (₹) --
Minimum Balance (₹) 5,000
Exit Load 1% for redemption within 364 days

Basic Details

Fund House: UTI Mutual Fund
Launch Date: 01-Aug-2005
Return Since Launch: 12.55%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 390 Cr (As on 29-Feb-2020)
Expense: 2.53% (As on 29-Feb-2020)
Risk Grade: --
Return Grade: --
Turnover: 45.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
Dividend28-Oct-20101.7000

 26-Aug-20081.5000
 10-Jan-20062.5000
 10-Nov-20042.5000
 21-Nov-20032.0000

Contact Information

AMC: UTI Asset Management Company Ltd

Address: UTI Tower, 'GN' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051

Phone: 022- 66786666 / 66786354 / 1800-22-1230

Fax: 022-26523031

Email: [email protected]

Website: www.utimf.com

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Last Session

Investors' Hangout

5 ways to deal with market panic

dateFriday, 20-Mar-2020
time12:30 PM - 01:00 PM

Registration Over